Get access

PHARMACOLOGIC MANAGEMENT OF COMMON LOWER RESPIRATORY TRACT DISORDERS IN WOMEN

Authors

  • Steven Leiner FNP, PA-C, MS,

    Search for more papers by this author
    • Steven Leiner completed his master's degree and nurse practitioner training at Pace University, Pleasantville, New York, in 1980. He is currently employed at Mission Neighborhood Health Center, San Francisco, CA. Mr. Leiner is an Assistant Clinical Professor in the Department of Family Health Care Nursing at the University of California, San Francisco.

  • Mary Mays CNM, FNP, MS

    Corresponding author
      1379 45th Avenue, San Francisco, CA 94122.
    Search for more papers by this author
    • Mary Mays completed her midwifery and family nurse practitioner training in 1985 at the Frontier School of Midwifery and Family Nursing in Hyden, Kentucky, and received her master's degree in 1992 from the University of California, San Francisco. She currently works as a nurse practitioner with the homeless program of the Department of Public Health in San Francisco and provides prenatal care in the midwifery service at San Francisco General Hospital. Ms. Mays is an Assistant Clinical Professor in the Department of Family Health Care Nursing at the University of California, San Francisco.


  • CNMs/CMs and midwives as used herein refer to those midwifery practitioners who are certified by the American College of Nurse-Midwives (ACNM) or the ACNM Certification Council, Inc.; midwifery refers to the profession as practiced in accordance with the standards promulgated by the ACNM.

1379 45th Avenue, San Francisco, CA 94122.

ABSTRACT

In a primary care setting, midwives collaboratively manage common lower respiratory conditions that require pharmacologic therapy. Current knowledge about the indications, use, adverse effects, and potential side effects of these medications is essential. This article reviews the drugs most frequently used for the outpatient treatment of asthma, tuberculosis, pneumonia, and bronchitis (acute and chronic) in adults. Recommendations from the Centers for Disease Control and Prevention guidelines and professional societies are presented. Drug pharmacology and adverse effects are discussed in detail.

Get access to the full text of this article

Ancillary